- Protein Name
- Dual specificity mitogen-activated protein kinase kinase 7
- Gene Name
- MAP2K7
- Organism
-
Homo sapiens
- Function
- Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.
Site |
Maximum Consensus Site Population |
Minimum Consensus Site Population |
Median Consensus Site Population |
MPP |
15 |
9 |
12.0 |
PIF |
5 |
5 |
5.0 |
DRS |
22 |
2 |
17.0 |
MT3 |
13 |
4 |
12.0 |
AAS |
25 |
4 |
11.0 |
LBP |
15 |
3 |
9.0 |
CMP |
15 |
2 |
8.0 |
PDIG |
5 |
3 |
4.0 |
ATP |
19 |
5 |
16.0 |
PDB ID |
Maximum Consensus Site Population |
MPP site |
DFG site |
PIF site |
DRS site |
DEF site |
EDI site |
MT3 site |
AAS site |
LBP site |
CMP site |
PDIG site |
ATP site |
PMP site |
Total Druggable Structures per Site |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
3 |
0 |
5B2K
|
0 |
0 |
0 |
17 |
0 |
0 |
4 |
16 |
15 |
6 |
5 |
19 |
0 |
3WZU
|
0 |
0 |
5 |
22 |
0 |
0 |
13 |
11 |
0 |
15 |
3 |
5 |
0 |
5B2M
|
0 |
0 |
0 |
20 |
0 |
0 |
12 |
11 |
0 |
13 |
0 |
13 |
0 |
2DYL
|
15 |
0 |
0 |
20 |
0 |
0 |
0 |
25 |
0 |
8 |
0 |
16 |
0 |
5B2L
|
9 |
0 |
0 |
12 |
0 |
0 |
0 |
9 |
3 |
2 |
0 |
19 |
0 |